Literature DB >> 27076920

VATS lobectomy facilitates the delivery of adjuvant docetaxel-carboplatin chemotherapy in patients with non-small cell lung cancer.

Thomas A D'Amico1.   

Abstract

Entities:  

Year:  2016        PMID： 27076920      PMCID： PMC4805810          DOI： 10.21037/jtd.2016.02.36

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  5 in total

Review 1.  Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer.

Authors:  Tristan D Yan; Deborah Black; Paul G Bannon; Brian C McCaughan
Journal:  J Clin Oncol       Date:  2009-03-16       Impact factor: 44.544

2.  A systematic review and meta-analysis on pulmonary resections by robotic video-assisted thoracic surgery.

Authors:  Christopher Cao; Con Manganas; Su C Ang; Tristan D Yan
Journal:  Ann Cardiothorac Surg       Date:  2012-05

3.  VATS lobectomy facilitates the delivery of adjuvant docetaxel-carboplatin chemotherapy in patients with non-small cell lung cancer.

Authors:  Xiuyi Zhi; Wen Gao; Baohui Han; Yue Yang; Hui Li; Deruo Liu; Changli Wang; Gong Min; Hao Long; James R Rigas; Mark Carey; Thierry Jahan; Amanda Sammann; Joseph Reza; Daoyuan Wang; Michael J Mann; David M Jablons; Jianxing He
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

4.  Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer.

Authors:  Rebecca P Petersen; DuyKhanh Pham; William R Burfeind; Steven I Hanish; Eric M Toloza; David H Harpole; Thomas A D'Amico
Journal:  Ann Thorac Surg       Date:  2007-04       Impact factor: 4.330

5.  Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up.

Authors:  G Bonadonna; P Valagussa; A Moliterni; M Zambetti; C Brambilla
Journal:  N Engl J Med       Date:  1995-04-06       Impact factor: 91.245
  5 in total
  2 in total

1.  Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer.

Authors:  Sai Yendamuri; Adrienne Groman; Austin Miller; Todd Demmy; Mark Hennon; Elisabeth Dexter; Anthony Picone; Chukwumere Nwogu; Grace K Dy
Journal:  Eur J Cardiothorac Surg       Date:  2018-03-01       Impact factor: 4.191

2.  Short-term local control after VATS segmentectomy and lobectomy for solid NSCLC of less than 2 cm.

Authors:  Marc Darras; Amaya Ojanguren; Céline Forster; Matthieu Zellweger; Jean Yannis Perentes; Thorsten Krueger; Michel Gonzalez
Journal:  Thorac Cancer       Date:  2020-12-03       Impact factor: 3.500
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.